---
layout: default
title: Milrinone
description: "Milrinone çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚æ¨¡å‹é æ¸¬ç­‰ç´š L5ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: åƒ…æ¨¡å‹é æ¸¬ (L5)
nav_order: 106
evidence_level: L1
indication_count: 10
---

# Milrinone

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L5</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Milrinone è—¥å¸«ç­†è¨˜

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Milrinone å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Milrinone æ˜¯ä¸€ç¨®ç£·é…¸äºŒé…¯é…¶æŠ‘åˆ¶åŠ‘ï¼ŒTxGNN é æ¸¬å…¶å°ç¦¿é«®ç—‡åŠé ­ç—›éšœç¤™æœ‰æ½›åŠ›ï¼Œå…¶ä¸­é ­ç—›éšœç¤™ï¼ˆç‰¹åˆ¥æ˜¯å¯é€†æ€§è…¦è¡€ç®¡æ”¶ç¸®ç—‡å€™ç¾¤ç›¸é—œé ­ç—›ï¼‰å·²æœ‰ç—…ä¾‹å ±å‘Šæ”¯æŒå‹•è„ˆå…§ Milrinone çš„ç™‚æ•ˆã€‚
</p>

---

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| è—¥ç‰©åç¨± | Milrinoneï¼ˆç±³åŠ›å¿ƒï¼‰ |
| DrugBank ID | DB00235 |
| å°ç£å•†å“å | ç±³åŠ›å¿ƒæ³¨å°„åŠ‘0.2æ¯«å…‹/æ¯«å‡ |
| åŸæ ¸å‡†é©æ‡‰ç—‡ | å……è¡€æ€§å¿ƒè¡°ç«­çš„çŸ­æœŸç™‚æ³• |
| é æ¸¬æ–°é©æ‡‰ç—‡ | alopeciaã€hypotrichosis simplex of the scalpã€congenital hypotrichosis miliaã€diffuse alopecia areataã€headache disorderã€congestive heart failureã€migraine disorderã€migraine with brainstem auraã€trigeminal autonomic cephalalgiaã€acute pulmonary heart disease |
| æœ€é«˜é æ¸¬åˆ†æ•¸ | 0.9991ï¼ˆç¦¿é«®ç—‡ï¼‰ |
| è­‰æ“šç­‰ç´š | L3ï¼ˆè§€å¯Ÿæ€§ç ”ç©¶/ç—…ä¾‹å ±å‘Š - é ­ç—›éšœç¤™ï¼‰ |

---





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. alopecia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.91%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p>### è—¥ç†æ©Ÿè½‰åˆ†æ</p>

<p>Milrinone æ˜¯é¸æ“‡æ€§ç£·é…¸äºŒé…¯é…¶-3ï¼ˆPDE3ï¼‰æŠ‘åˆ¶åŠ‘ï¼Œé€éå¢åŠ ç´°èƒå…§ cAMP æ¿ƒåº¦ç™¼æ®ä½œç”¨ã€‚å…¶æ©Ÿè½‰èˆ‡é æ¸¬é©æ‡‰ç—‡çš„é—œè¯ï¼š</p>

<ol>
<li><strong>ç¦¿é«®ç—‡/æ¯›é«®ç¨€ç–ç—‡</strong>ï¼ˆTxGNN Score: 0.9991ï¼‰</li>
</ol>
<ul>
<li>PDE æŠ‘åˆ¶åŠ‘ï¼ˆå¦‚ minoxidilï¼‰å·²çŸ¥å¯ä¿ƒé€²æ¯›é«®ç”Ÿé•·</li>
<li>Milrinone ä½œç‚º PDE3 æŠ‘åˆ¶åŠ‘ç†è«–ä¸Šå¯èƒ½æœ‰é¡ä¼¼ä½œç”¨</li>
<li>ä½†ç¼ºä¹ç›´æ¥è­‰æ“š</li>

</ul>
<ol>
<li><strong>é ­ç—›éšœç¤™</strong>ï¼ˆTxGNN Score: 0.9946ï¼‰</li>
</ol>
<ul>
<li>Milrinone å…·æœ‰è¡€ç®¡æ“´å¼µä½œç”¨</li>
<li>å·²æœ‰ç—…ä¾‹å ±å‘Šé¡¯ç¤ºå‹•è„ˆå…§ Milrinone å¯ç”¨æ–¼æ²»ç™‚å¯é€†æ€§è…¦è¡€ç®¡æ”¶ç¸®ç—‡å€™ç¾¤ï¼ˆRCVSï¼‰</li>
<li>é€éè§£é™¤è…¦è¡€ç®¡ç—™æ”£ä¾†ç·©è§£é ­ç—›</li>

</ul>
<ol>
<li><strong>å……è¡€æ€§å¿ƒè¡°ç«­</strong>ï¼ˆTxGNN Score: 0.9945ï¼‰</li>
</ol>
<ul>
<li>æ­¤ç‚ºåŸæ ¸å‡†é©æ‡‰ç—‡ï¼Œæœ‰è±å¯Œè‡¨åºŠè©¦é©—è­‰æ“š</li>
</ul>

<h3>è‡¨åºŠè©¦é©—</h3>

<p>ç›®å‰ç„¡é‡å°æ­¤ç‰¹å®šé©æ‡‰ç—‡çš„è‡¨åºŠè©¦é©—ç™»è¨˜ã€‚</p>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. hypotrichosis simplex of the scalp</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.90%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. congenital hypotrichosis milia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.89%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. diffuse alopecia areata</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.88%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. headache disorder</span>
<span class="evidence-badge evidence-L3">L3</span>
<span class="prediction-score">99.46%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ1 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06205758" target="_blank">NCT06205758</a></td><td>N/A</td><td>UNKNOWN</td><td>1600</td><td>Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ3 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/34784343/" target="_blank">34784343</a></td><td>2021</td><td>Article</td><td>The American journal of case r</td><td>Reversible Cerebral Vasoconstriction Syndrome in a Background of Eclampsia Respo...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25440342/" target="_blank">25440342</a></td><td>2015</td><td>Article</td><td>Journal of stroke and cerebrov</td><td>A novel approach to diagnose reversible cerebral vasoconstriction syndrome: a ca...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/18647181/" target="_blank">18647181</a></td><td>2009</td><td>Article</td><td>Headache</td><td>Intra-arterial milrinone for reversible cerebral vasoconstriction syndrome.</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. congestive heart failure</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.45%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ50 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01301313" target="_blank">NCT01301313</a></td><td>PHASE2</td><td>TERMINATED</td><td>116</td><td>Phase II Study to Evaluate the Efficacy and Safety of Levosimendan in Severe Acu...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02098629" target="_blank">NCT02098629</a></td><td>PHASE2</td><td>COMPLETED</td><td>25</td><td>Concomitant Milrinone and Esmolol Treatment in Patients with Acute Myocardial In...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04369573" target="_blank">NCT04369573</a></td><td>PHASE4</td><td>TERMINATED</td><td>100</td><td>Early Intra-aortic Balloon Pump Placement in Acute Decompensated Heart Failure C...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06522594" target="_blank">NCT06522594</a></td><td>PHASE2</td><td>RECRUITING</td><td>20</td><td>Randomized Embedded Multifactorial Adaptive Platform in ExtraCorporeal Membrane ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03071835" target="_blank">NCT03071835</a></td><td>N/A</td><td>COMPLETED</td><td>47</td><td>A Comparative Study of Subjects tHree to Thirteen Years Past thEiR fInal Follow-...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05202938" target="_blank">NCT05202938</a></td><td>N/A</td><td>UNKNOWN</td><td>32</td><td>Energy MEtabolism of Septic Heart.</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04092855" target="_blank">NCT04092855</a></td><td>N/A</td><td>RECRUITING</td><td>112</td><td>Early Identification and Prediction of Right Ventricular Dysfunction and Failure...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04573049" target="_blank">NCT04573049</a></td><td>PHASE4</td><td>UNKNOWN</td><td>124</td><td>A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Effectivene...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01576094" target="_blank">NCT01576094</a></td><td>PHASE1, PHASE2</td><td>COMPLETED</td><td>20</td><td>Phase I Study of Two Inodilators in Neonates Undergoing Cardiovascular Surgery</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01971944" target="_blank">NCT01971944</a></td><td>N/A</td><td>COMPLETED</td><td>50</td><td>The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope In...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04694092" target="_blank">NCT04694092</a></td><td>NA</td><td>UNKNOWN</td><td>40</td><td>Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrilla...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03836482" target="_blank">NCT03836482</a></td><td>NA</td><td>NOT_YET_RECRUITING</td><td>20</td><td>Feasibility Study to Assess the Safety and Efficacy of a Selective Cytopheretic ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01616069" target="_blank">NCT01616069</a></td><td>PHASE4</td><td>COMPLETED</td><td>81</td><td>Assessment and Hemodynamic Response in CABG After Cardiopulmonary Bypass Using I...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01364636" target="_blank">NCT01364636</a></td><td>N/A</td><td>TERMINATED</td><td>180</td><td>Accuracy of Urinary Neutrophil Gelatinase-Associated Lipocalin (NGAL) in Predict...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03574311" target="_blank">NCT03574311</a></td><td>PHASE4</td><td>UNKNOWN</td><td>210</td><td>A Phase IV Double-blind, Randomised, Parallel Group Comparison of the Efficacy a...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT07186062" target="_blank">NCT07186062</a></td><td>N/A</td><td>COMPLETED</td><td>60</td><td>Clinical Outcomes of Levosimendan Versus Dobutamine Versus Milrinone in Cases Wi...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05700617" target="_blank">NCT05700617</a></td><td>EARLY_PHASE1</td><td>RECRUITING</td><td>5</td><td>Myocardial Reserve in Advanced Heart Failure Patients</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06595264" target="_blank">NCT06595264</a></td><td>N/A</td><td>COMPLETED</td><td>19</td><td>Patients With Aneurysms of the Vein of Galen, H.U.B Experience; a Retrospective ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03631654" target="_blank">NCT03631654</a></td><td>PHASE4</td><td>WITHDRAWN</td><td>0</td><td>Ivabradine in Stage D Heart Failure Patients on Chronic Inotropes: A Pilot Study</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04718350" target="_blank">NCT04718350</a></td><td>NA</td><td>COMPLETED</td><td>40</td><td>Comparison of Intravenous Levosimendan and Inhalational Milrinone in High Risk C...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06205758" target="_blank">NCT06205758</a></td><td>N/A</td><td>UNKNOWN</td><td>1600</td><td>Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05999487" target="_blank">NCT05999487</a></td><td>NA</td><td>UNKNOWN</td><td>40</td><td>Dobutamine Versus Milrinone in Management of Critically Ill Low Cardiac Output P...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04014010" target="_blank">NCT04014010</a></td><td>N/A</td><td>COMPLETED</td><td>35000</td><td>Machine Learning Modeling of Intraoperative Hemodynamic Predictors of 30-day Mor...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03180450" target="_blank">NCT03180450</a></td><td>PHASE1, PHASE2</td><td>SUSPENDED</td><td>60</td><td>The Study of Heart Failure With Human Umbilical Cord Mesenchymal Stem Cells (hUC...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05063370" target="_blank">NCT05063370</a></td><td>PHASE2</td><td>UNKNOWN</td><td>40</td><td>Perioperative Use of Levosimendan in Patients With Impaired Right Ventricular Fu...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02606253" target="_blank">NCT02606253</a></td><td>PHASE4</td><td>COMPLETED</td><td>60</td><td>Comparison of Oral Thiazides vs Intravenous Thiazides vs Tolvaptan in Combinatio...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04682483" target="_blank">NCT04682483</a></td><td>N/A</td><td>RECRUITING</td><td>5000</td><td>Cardiogenic Shock Working Group Registry</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03160846" target="_blank">NCT03160846</a></td><td>N/A</td><td>COMPLETED</td><td>129</td><td>Inotrope, Evaluation and Research (INTERPRET) Patient Registry Program</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04184674" target="_blank">NCT04184674</a></td><td>NA</td><td>COMPLETED</td><td>50</td><td>Impact of the Transpulmonary Pressure on Right Ventricle Function in Acute Respi...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04458103" target="_blank">NCT04458103</a></td><td>NA</td><td>TERMINATED</td><td>161</td><td>Percutaneous RVAD to Preemptively Treat Right Heart Failure Post-LVAD</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04015973" target="_blank">NCT04015973</a></td><td>NA</td><td>UNKNOWN</td><td>116</td><td>A Randomised Controlled Trial of a Pre-operative High Energy Diet for the Preven...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00338455" target="_blank">NCT00338455</a></td><td>PHASE2</td><td>TERMINATED</td><td>16</td><td>Investigation of the Use of Natrecor (Nesiritide) in Transplant-Eligible Managem...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04782154" target="_blank">NCT04782154</a></td><td>N/A</td><td>COMPLETED</td><td>136</td><td>Paceport Swan-Ganz Data Collection Study</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02728128" target="_blank">NCT02728128</a></td><td>N/A</td><td>COMPLETED</td><td>53</td><td>Platelet and Tissue cAMP: Novel Biomarkers of Milrinone Efficacy in Children</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01571037" target="_blank">NCT01571037</a></td><td>PHASE1</td><td>COMPLETED</td><td>10</td><td>Inhaled Milrinone Use in Patients Receiving HeartMate II LVAD: A Pilot Study</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06800716" target="_blank">NCT06800716</a></td><td>N/A</td><td>RECRUITING</td><td>50</td><td>A Prospective Study of Recovery Mechanisms in Heart Transplant Eligible Patients...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05450328" target="_blank">NCT05450328</a></td><td>PHASE2</td><td>NOT_YET_RECRUITING</td><td>141</td><td>Inhaled Milrinone and Epoprostenol for the Prevention of Difficult Cardiac Pulmo...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00060840" target="_blank">NCT00060840</a></td><td>PHASE2</td><td>COMPLETED</td><td>150</td><td>The Effects of Nitric Oxide for Inhalation During Left Ventricular Assist Device...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02644057" target="_blank">NCT02644057</a></td><td>PHASE2</td><td>WITHDRAWN</td><td>0</td><td>Comparison of Dobutamine Versus Milrinone for Renal Recovery in Patients With Ca...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04586764" target="_blank">NCT04586764</a></td><td>N/A</td><td>UNKNOWN</td><td>500</td><td>ST Elevation Myocardial Infarction Hemodynamic OutComes: Role of Non-Invasive Ca...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04278404" target="_blank">NCT04278404</a></td><td>N/A</td><td>RECRUITING</td><td>5000</td><td>Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02077010" target="_blank">NCT02077010</a></td><td>PHASE1</td><td>COMPLETED</td><td>10</td><td>Nebulized Inhaled Milrinone in a Hospitalized Advanced Heart Failure Population</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT07175948" target="_blank">NCT07175948</a></td><td>N/A</td><td>NOT_YET_RECRUITING</td><td>100</td><td>Outcome of Different Clinical Phenotypes of Myocarditis in Children Admitted to ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT07019987" target="_blank">NCT07019987</a></td><td>NA</td><td>NOT_YET_RECRUITING</td><td>80</td><td>Imaging the Respiratory Effects of Truncal Adiposity in Acute Hypoxemic Respirat...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01956006" target="_blank">NCT01956006</a></td><td>PHASE1, PHASE2</td><td>COMPLETED</td><td>26</td><td>Pilot Study of Slow Release Oral Milrinone in Patients With Advanced Heart Failu...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05064202" target="_blank">NCT05064202</a></td><td>NA</td><td>NOT_YET_RECRUITING</td><td>456</td><td>Use of mechaNical Left ventricuLar unlOading in Acute decompensateD Heart Failur...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05801224" target="_blank">NCT05801224</a></td><td>NA</td><td>SUSPENDED</td><td>70</td><td>Regional Vascular Recruitment With Inhaled Nitric Oxide in Patients With ARDS</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02408003" target="_blank">NCT02408003</a></td><td>NA</td><td>COMPLETED</td><td>30</td><td>What Are the Changes in Cardiac Deformation Variables and Hemodynamic Parameters...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04298229" target="_blank">NCT04298229</a></td><td>PHASE3</td><td>COMPLETED</td><td>240</td><td>A Randomized, Open-label Study of Dapagliflozin in Patients With or Without Type...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01849094" target="_blank">NCT01849094</a></td><td>PHASE1, PHASE2</td><td>COMPLETED</td><td>9</td><td>Evaluating the Safety, Pharmacokinetics and Haemodynamic Effect of a Slow Releas...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35545181/" target="_blank">35545181</a></td><td>2023</td><td>Article</td><td>Current problems in cardiology</td><td>Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Dec...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3012226/" target="_blank">3012226</a></td><td>1986</td><td>Article</td><td>The Medical clinics of North A</td><td>Congestive heart failure.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31865433/" target="_blank">31865433</a></td><td>2020</td><td>Article</td><td>Heart and vessels</td><td>Comparing the effects of milrinone and olprinone in patients with congestive hea...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36122816/" target="_blank">36122816</a></td><td>2022</td><td>Article</td><td>Journal of cardiac failure</td><td>Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milri...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22664586/" target="_blank">22664586</a></td><td>2012</td><td>Article</td><td>Circulation journal : official</td><td>Combination of Î²-blocker and milrinone for acute heart failure.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35243658/" target="_blank">35243658</a></td><td>2022</td><td>Article</td><td>Clinical cardiology</td><td>Repetitive milrinone therapy in ambulatory advanced heart failure patients.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32552221/" target="_blank">32552221</a></td><td>2020</td><td>Article</td><td>Journal of the American Heart </td><td>Old Drug, New Trick? Oral Milrinone for Heart Failure With Preserved Ejection Fr...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38147129/" target="_blank">38147129</a></td><td>2024</td><td>Article</td><td>European journal of pediatrics</td><td>Milrinone in pediatric heart failure and pulmonary hypertension: Is meta-analyse...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37891490/" target="_blank">37891490</a></td><td>2023</td><td>Article</td><td>BMC pediatrics</td><td>Milrinone for the treatment of heart failure caused by severe Pneumonia in child...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38547524/" target="_blank">38547524</a></td><td>2024</td><td>Article</td><td>Journal of cardiovascular phar</td><td>Comparative Effectiveness and Safety of Intermittent, Repeated, or Continuous Us...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/4050707/" target="_blank">4050707</a></td><td>1985</td><td>Article</td><td>The American journal of cardio</td><td>Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart f...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/23620310/" target="_blank">23620310</a></td><td>2014</td><td>Article</td><td>Angiology</td><td>Milrinone in advanced heart failure: dose and therapeutic monitor outside intens...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37322827/" target="_blank">37322827</a></td><td>2023</td><td>Article</td><td>ESC heart failure</td><td>Improved mortality and haemodynamics with milrinone in cardiogenic shock due to ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36417945/" target="_blank">36417945</a></td><td>2023</td><td>Article</td><td>Journal of pain and symptom ma</td><td>Home Milrinone in Pediatric Hospice Care of Children with Heart Failure.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/1949499/" target="_blank">1949499</a></td><td>1991</td><td>Article</td><td>The Veterinary clinics of Nort</td><td>The efficacy and safety of milrinone for treating heart failure in dogs.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37909442/" target="_blank">37909442</a></td><td>2024</td><td>Article</td><td>Current medicinal chemistry</td><td>Current Targets and Future Directions of Positive Inotropes for Heart Failure.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2658377/" target="_blank">2658377</a></td><td>1989</td><td>Article</td><td>DICP : the annals of pharmacot</td><td>Role of milrinone in the management of congestive heart failure.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/35384369/" target="_blank">35384369</a></td><td>2022</td><td>Article</td><td>ESC heart failure</td><td>Milrinone or dobutamine in patients with heart failure: evidence from meta-analy...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36229299/" target="_blank">36229299</a></td><td>2022</td><td>Article</td><td>Heart, lung &amp; circulation</td><td>Long-Term Ambulatory Intravenous Milrinone Therapy in Advanced Heart Failure.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37999764/" target="_blank">37999764</a></td><td>2024</td><td>Article</td><td>European journal of pediatrics</td><td>Reassessing the role of milrinone in the treatment of heart failure and pulmonar...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. migraine disorder</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.45%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. migraine with brainstem aura</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.38%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. trigeminal autonomic cephalalgia</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.25%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. acute pulmonary heart disease</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.19%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ27 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05049590" target="_blank">NCT05049590</a></td><td>PHASE3</td><td>COMPLETED</td><td>63</td><td>Acute Normovolemic Hemodilution (ANH) in Complex Cardiac Surgery</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05194514" target="_blank">NCT05194514</a></td><td>NA</td><td>COMPLETED</td><td>20</td><td>Randomized Trial to Compare the SherpaPakâ„¢ Device vs Cold Storage of Donor Heart...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04092855" target="_blank">NCT04092855</a></td><td>N/A</td><td>RECRUITING</td><td>112</td><td>Early Identification and Prediction of Right Ventricular Dysfunction and Failure...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01971944" target="_blank">NCT01971944</a></td><td>N/A</td><td>COMPLETED</td><td>50</td><td>The Influence of Beta Blocker Therapy on the Hemodynamic Response to Inotrope In...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04694092" target="_blank">NCT04694092</a></td><td>NA</td><td>UNKNOWN</td><td>40</td><td>Landiolol for Rate Control in Decompensated Heart Failure Due to Atrial Fibrilla...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04182945" target="_blank">NCT04182945</a></td><td>NA</td><td>TERMINATED</td><td>20</td><td>Fever Algorithm Development of a Non-invasive Wearable Core Body Temperature Sen...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03836482" target="_blank">NCT03836482</a></td><td>NA</td><td>NOT_YET_RECRUITING</td><td>20</td><td>Feasibility Study to Assess the Safety and Efficacy of a Selective Cytopheretic ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06361420" target="_blank">NCT06361420</a></td><td>NA</td><td>RECRUITING</td><td>43</td><td>The Efficacy of Driving Pressure-guided Lung Protective Ventilation in Surgical ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02549066" target="_blank">NCT02549066</a></td><td>NA</td><td>COMPLETED</td><td>18</td><td>Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenat...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05253209" target="_blank">NCT05253209</a></td><td>PHASE3</td><td>TERMINATED</td><td>64</td><td>A Phase III Double-Blind, Randomized, Placebo Controlled, Multi Center Clinical ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03335865" target="_blank">NCT03335865</a></td><td>N/A</td><td>COMPLETED</td><td>100</td><td>Noninvasive Measurements of Renal Perfusion During Cardiac Surgery</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT07231107" target="_blank">NCT07231107</a></td><td>NA</td><td>COMPLETED</td><td>90</td><td>Comparative Study Between Airway Pressure Release Ventilation and Pressure Regul...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04014010" target="_blank">NCT04014010</a></td><td>N/A</td><td>COMPLETED</td><td>35000</td><td>Machine Learning Modeling of Intraoperative Hemodynamic Predictors of 30-day Mor...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04184674" target="_blank">NCT04184674</a></td><td>NA</td><td>COMPLETED</td><td>50</td><td>Impact of the Transpulmonary Pressure on Right Ventricle Function in Acute Respi...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04015973" target="_blank">NCT04015973</a></td><td>NA</td><td>UNKNOWN</td><td>116</td><td>A Randomised Controlled Trial of a Pre-operative High Energy Diet for the Preven...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04782154" target="_blank">NCT04782154</a></td><td>N/A</td><td>COMPLETED</td><td>136</td><td>Paceport Swan-Ganz Data Collection Study</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05757557" target="_blank">NCT05757557</a></td><td>PHASE1, PHASE2</td><td>COMPLETED</td><td>136</td><td>Perioperative Nitric oxiDE-conditioning, Produced by Plasma-chemical Synthesis T...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06800716" target="_blank">NCT06800716</a></td><td>N/A</td><td>RECRUITING</td><td>50</td><td>A Prospective Study of Recovery Mechanisms in Heart Transplant Eligible Patients...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03207165" target="_blank">NCT03207165</a></td><td>PHASE4</td><td>COMPLETED</td><td>192</td><td>Comparison of Milrinone Versus Dobutamine in a Heterogeneous Population of Criti...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01864252" target="_blank">NCT01864252</a></td><td>PHASE3</td><td>COMPLETED</td><td>192</td><td>The Effect of Remote Ischaemic Preconditioning and Glyceryl Trinitrate on Peri-o...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04586764" target="_blank">NCT04586764</a></td><td>N/A</td><td>UNKNOWN</td><td>500</td><td>ST Elevation Myocardial Infarction Hemodynamic OutComes: Role of Non-Invasive Ca...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05740397" target="_blank">NCT05740397</a></td><td>NA</td><td>RECRUITING</td><td>900</td><td>Mean Arterial Pressure (MAP) Trial: Study Protocol for a Multicenter, Randomized...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT07019987" target="_blank">NCT07019987</a></td><td>NA</td><td>NOT_YET_RECRUITING</td><td>80</td><td>Imaging the Respiratory Effects of Truncal Adiposity in Acute Hypoxemic Respirat...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02280239" target="_blank">NCT02280239</a></td><td>PHASE4</td><td>TERMINATED</td><td>10</td><td>Safety and Antipyretic Efficacy of Acetaminophen in the Febrile Intensive Care U...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02836899" target="_blank">NCT02836899</a></td><td>PHASE3</td><td>ACTIVE_NOT_RECRUITING</td><td>250</td><td>Prevention of Acute Kidney Injury by Nitric Oxide in Prolonged Cardiopulmonary B...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02891837" target="_blank">NCT02891837</a></td><td>PHASE3</td><td>COMPLETED</td><td>189</td><td>A Phase III Double-Blind, Randomized, Placebo Controlled, Multi-Center Clinical ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05801224" target="_blank">NCT05801224</a></td><td>NA</td><td>SUSPENDED</td><td>70</td><td>Regional Vascular Recruitment With Inhaled Nitric Oxide in Patients With ARDS</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8659556/" target="_blank">8659556</a></td><td>1996</td><td>Article</td><td>The American journal of the me</td><td>Milrinone: basic and clinical pharmacology and acute and chronic management.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11096492/" target="_blank">11096492</a></td><td>1999</td><td>Article</td><td>Current treatment options in c</td><td>Acute Pulmonary Edema.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16582544/" target="_blank">16582544</a></td><td>2006</td><td>Article</td><td>Cardiology</td><td>Medical and ventilatory treatment of acute heart failure: new insights.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16541166/" target="_blank">16541166</a></td><td>2006</td><td>Article</td><td>Tidsskrift for den Norske laeg</td><td>[Medical and ventilatory treatment of acute heart failure].</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/21678708/" target="_blank">21678708</a></td><td>2011</td><td>Article</td><td>Prescrire international</td><td>Acute heart failure with dyspnoea: initial treatment. Furosemide and trinitrine,...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11792300/" target="_blank">11792300</a></td><td>2001</td><td>Article</td><td>Revista espanola de anestesiol</td><td>[The pulmonary vasodilatory effect of inhaled prostacyclin and milrinone in hear...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/20056439/" target="_blank">20056439</a></td><td>2010</td><td>Article</td><td>Journal of cardiothoracic and </td><td>Inhaled nitroglycerin versus inhaled milrinone in children with congenital heart...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28793822/" target="_blank">28793822</a></td><td>2017</td><td>Article</td><td>Journal of cardiovascular phar</td><td>Dose-Response Head-to-Head Comparison of Inodilators Dobutamine, Milrinone, and ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33561307/" target="_blank">33561307</a></td><td>2021</td><td>Article</td><td>Pediatric pulmonology</td><td>Intensive care management of right ventricular failure and pulmonary hypertensio...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/7728786/" target="_blank">7728786</a></td><td>1995</td><td>Article</td><td>Cardiology</td><td>Hemodynamic effects and pharmacokinetics of oral milrinone for short-term suppor...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8903534/" target="_blank">8903534</a></td><td>1996</td><td>Article</td><td>Clinical cardiology</td><td>Comparative efficacy of short-term intravenous infusions of milrinone and dobuta...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/18303526/" target="_blank">18303526</a></td><td>2008</td><td>Article</td><td>Current opinion in cardiology</td><td>New therapies in acute decompensated heart failure.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22481100/" target="_blank">22481100</a></td><td>2012</td><td>Article</td><td>Circulation journal : official</td><td>Low-dose Î²-blocker in combination with milrinone safely improves cardiac functio...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/8797620/" target="_blank">8797620</a></td><td>1996</td><td>Article</td><td>Critical care medicine</td><td>Multicenter, double-blind study of intravenous milrinone for patients with acute...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9673832/" target="_blank">9673832</a></td><td>1998</td><td>Article</td><td>Clinical pharmacokinetics</td><td>Clinical pharmacokinetics of vasodilators. Part II.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/2035427/" target="_blank">2035427</a></td><td>1991</td><td>Article</td><td>American heart journal</td><td>Hemodynamic and clinical benefits with intravenous milrinone in severe chronic h...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3953354/" target="_blank">3953354</a></td><td>1986</td><td>Article</td><td>American heart journal</td><td>Occurrence of ventricular arrhythmias in patients receiving acute and chronic in...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37980253/" target="_blank">37980253</a></td><td>2023</td><td>Article</td><td>Transplantation proceedings</td><td>Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/20497611/" target="_blank">20497611</a></td><td>2010</td><td>Article</td><td>Critical care (London, England</td><td>Clinical review: practical recommendations on the management of perioperative he...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/3976517/" target="_blank">3976517</a></td><td>1985</td><td>Article</td><td>The American journal of cardio</td><td>Acute dose range study of milrinone in congestive heart failure.</td></tr>
</tbody>
</table>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰å­—è™Ÿ | å•†å“å | åŠ‘å‹ | è¨±å¯è­‰æŒæœ‰è€… | ç‹€æ…‹ |
|-----------|--------|------|-------------|------|
| ï¼ˆå¾…ç¢ºèªï¼‰ | ç±³åŠ›å¿ƒæ³¨å°„åŠ‘0.2æ¯«å…‹/æ¯«å‡ | æ³¨å°„åŠ‘ | ï¼ˆå¾…ç¢ºèªï¼‰ | æœ‰æ•ˆ |

**é©æ‡‰ç—‡**ï¼šå……è¡€æ€§å¿ƒè¡°ç«­çš„çŸ­æœŸç™‚æ³•ã€‚éœ€åœ¨æœ‰é©ç•¶å¿ƒé›»åœ–ç›£æ¸¬è¨­å‚™çš„ç’°å¢ƒä¸‹ä½¿ç”¨ã€‚

---

## å®‰å…¨æ€§è€ƒé‡

### ä½¿ç”¨æ³¨æ„äº‹é …

1. **å¿ƒå¾‹ä¸æ•´é¢¨éšª**
   - å¯èƒ½å¼•èµ·å±åŠç”Ÿå‘½çš„å®¤æ€§å¿ƒå¾‹ä¸æ•´
   - éœ€æŒçºŒå¿ƒé›»åœ–ç›£æ¸¬

2. **ä½¿ç”¨é™åˆ¶**
   - ç›®å‰ç„¡ä½¿ç”¨è¶…é 48 å°æ™‚çš„å°ç…§è©¦é©—ç¶“é©—
   - å»ºè­°åƒ…ä½œç‚ºçŸ­æœŸç™‚æ³•

3. **è—¥ç‰©äº¤äº’ä½œç”¨**
   - å¸¸èˆ‡ digoxin å’Œåˆ©å°¿åŠ‘ä½µç”¨
   - èˆ‡å…¶ä»–å¼·å¿ƒè—¥ç‰©ä½µç”¨æ™‚éœ€è¬¹æ…

### çµ¦è—¥é€”å¾‘è€ƒé‡

- **éœè„ˆæ³¨å°„**ï¼šå¿ƒè¡°ç«­æ¨™æº–çµ¦è—¥æ–¹å¼
- **å‹•è„ˆå…§æ³¨å°„**ï¼šRCVS æ²»ç™‚çš„ç ”ç©¶çµ¦è—¥æ–¹å¼ï¼Œéœ€å°ˆæ¥­ä»‹å…¥è¨­å‚™
- **å¸å…¥çµ¦è—¥**ï¼šè‚ºé«˜å£“æ²»ç™‚çš„ç ”ç©¶çµ¦è—¥æ–¹å¼

---


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**è‚è‡Ÿç–¾ç—…** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šè‚æ¯’æ€§ã€‚

**ä½è¡€å£“** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚

**Thrombocytopenia** ğŸŸ¡ Moderate
- é¢¨éšªåŒ…æ‹¬ï¼šè¡€æ “ã€‚å‡ºç¾ç—‡ç‹€æ™‚æ‡‰è€ƒæ…®åœè—¥ã€‚

**Arrhythmias, Cardiac** ğŸŸ¢ Minor
- éœ€å¯†åˆ‡ç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šå¿ƒå¾‹ä¸æ•´ã€‚å¯èƒ½æœ‰è‡´å‘½é¢¨éšªã€‚

**Heart Valve Diseases** ğŸŸ¢ Minor
- ä¸æ‡‰ä½¿ç”¨æœ¬è—¥ç‰©ã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚

**Myocardial Infarction** ğŸŸ¢ Minor
- ä¸å»ºè­°ä½¿ç”¨æœ¬è—¥ç‰©ã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

### è©•ä¼°çµè«–

| é æ¸¬é©æ‡‰ç—‡ | è­‰æ“šç­‰ç´š | è‡¨åºŠè½‰è­¯å¯è¡Œæ€§ | å»ºè­°å„ªå…ˆé †åº |
|-----------|---------|---------------|-------------|
| é ­ç—›éšœç¤™ï¼ˆRCVSï¼‰ | L3 | ä¸­ç­‰ | å»ºè­°é€²ä¸€æ­¥ç ”ç©¶ |
| ç¦¿é«®ç—‡ | L5 | ä½ | ä¸å»ºè­°å„ªå…ˆé–‹ç™¼ |
| å¿ƒè¡°ç«­ | L1 | é«˜ï¼ˆå·²æ ¸å‡†ï¼‰ | ä¸é©ç”¨ |

### å»ºè­°

1. **å¯é€†æ€§è…¦è¡€ç®¡æ”¶ç¸®ç—‡å€™ç¾¤ï¼ˆRCVSï¼‰**
   - ç›®å‰å·²æœ‰å¤šç¯‡ç—…ä¾‹å ±å‘Šæ”¯æŒå‹•è„ˆå…§ Milrinone çš„ç™‚æ•ˆ
   - å»ºè­°è¨­è¨ˆå‰ç»æ€§ç ”ç©¶è©•ä¼°å®‰å…¨æ€§å’Œæœ‰æ•ˆæ€§
   - å¯è€ƒæ…®ä½œç‚ºéˆ£é›¢å­é€šé“é˜»æ–·åŠ‘ç„¡æ•ˆæ™‚çš„æ•‘æ´æ²»ç™‚

2. **ç¦¿é«®ç—‡**
   - é›–ç„¶ PDE æŠ‘åˆ¶åŠ‘ç†è«–ä¸Šå¯èƒ½æœ‰æ•ˆ
   - ä½† Milrinone ç‚ºæ³¨å°„åŠ‘å‹ï¼Œä¸é©åˆå±€éƒ¨å¤–ç”¨æ²»ç™‚ç¦¿é«®
   - ä¸å»ºè­°é€²ä¸€æ­¥é–‹ç™¼

### å¾ŒçºŒè¡Œå‹•

- [x] ç¢ºèªé ­ç—›éšœç¤™æ–‡ç»è­‰æ“šï¼ˆå·²æœ‰ 3 ç¯‡ç—…ä¾‹å ±å‘Šï¼‰
- [ ] ç›£æ¸¬ RCVS æ²»ç™‚çš„æ–°è‡¨åºŠè©¦é©—
- [ ] è©•ä¼°æ˜¯å¦æœ‰å¯èƒ½é–‹ç™¼å±€éƒ¨å¤–ç”¨åŠ‘å‹ç”¨æ–¼ç¦¿é«®ï¼ˆå¯è¡Œæ€§ä½ï¼‰

---

*å ±å‘Šç”¢ç”Ÿæ—¥æœŸï¼š2026-02-11*
*è³‡æ–™ä¾†æºï¼šTxGNN é æ¸¬ã€ClinicalTrials.govã€PubMedã€å°ç£ FDA*

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Nitrofurantoin]({{ "/drugs/nitrofurantoin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Trabectedin]({{ "/drugs/trabectedin/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Zanubrutinib]({{ "/drugs/zanubrutinib/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Remdesivir]({{ "/drugs/remdesivir/" | relative_url }}) - è­‰æ“šç­‰ç´š L5
- [Cladribine]({{ "/drugs/cladribine/" | relative_url }}) - è­‰æ“šç­‰ç´š L5

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Milrinoneè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/milrinone/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_milrinone,
  title = {Milrinoneè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/milrinone/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
